Oct. 28 at 3:07 PM
                            
$BMPA On July 29, 2025, NeuralBase AI Ltd. (the “Company”) entered into an Asset Purchase Agreement (the “APA”) with Ahmed Mohammed Zaheer Uddin (the “Seller”), pursuant to which the Company acquired certain proprietary artificial intelligence assets known as HeartEase – AI-Powered Early Detection of Heart Abnormalities (the “Acquired Assets”).  Pursuant to the APA, the Company agreed to purchase the Acquired Assets in exchange for: (i) 1,000,000 shares of the Company’s Series A Preferred Stock, issued to the Seller at Closing; and (ii) a cash payment of 
$100,000 USD, payable no later than September 15, 2025. The APA contains customary representations, warranties, covenants, indemnification provisions, and closing conditions. The Acquired Assets, described in detail in Schedule 1.1 to the APA, include software, AI models, training datasets, intellectual property, and related materials comprising the HeartEase platform.